OFMDC Lung Cancer Screening Meeting Space

Lung Cancer Screening: Benefits of Scanning for Early Detection

March 27, 2023
6:15pm – 7:15pm ET

Speakers

Christian Rolfo, MD, PhD, MBA, Dr.hc. is Professor of Medicine (Hematology and Medical Oncology) and Associate Director for Clinical Research in the Center for Thoracic Oncology at The Tisch Cancer Institute. Dr. Rolfo’s clinical and research focus is on drug development, lung cancer and other thoracic malignancies, biomarkers, resistant mechanisms discovery, and liquid biopsies. Dr. Rolfo has held academic appointments at numerous institutions, including the University of Cordoba, Argentina; University of Antwerp, Belgium; University of Palermo, Italy, and the University of Maryland and Greenbaum Comprehensive Cancer Center where he was Director of Thoracic Medical Oncology and Director of Early Clinical Trials. Dr. Rolfo earned his MD at the University of Cordoba School of Medicine, his PhD and Doctor Europaeus in Clinical and Experimental Oncology Research at University of Palermo, Italy, and an MBA in Hospital and Health Services Management and Organization at Polytechnic University of Valencia, Spain. He completed residency training in Medical Oncology at the National Cancer Institute in Milan (University of Milan, Italy). Dr. Rolfo is President of the International Society of Liquid Biopsy (ISLB) and Chair of the Education Committee at the International Association for Study of Lung Cancer (IASLC). Dr. Rolfo served as member of the Drug Approval & First in Human Commission at the Ministry of Health in Belgium during his time as Phase I Director at Antwerp University.

CME Disclosure

CME Credentialing Statement: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of MedChi, The Maryland State Medical Society and Next Wave Group. MedChi is accredited by the ACCME to provide continuing medical education for physicians. MedChi designates this online educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Financial Disclosure

Presenter Christian Rolfo, MD, has reported the following relevant financial relationships with ineligible companies to disclose: EMD Serono, Advisory Board; ROCHE, Speakers Bureau; Mirati, Advisory Board ; Eisai, Advisory Board; COR2ED, Speakers Bureau; Daiichi Sankyo, Advisory Board; Sanofi Genzyme- Regeneron,Advisory Board; Blueprint, Advisory Board; Physicians Education Resource, Speakers Bureau; Intellisphere, Speakers Bureau; CEA, Advisory Board; Bayer, Advisory Board; General Dynamics, Advisory Board; Medstar, Advisory Board; Amgen, Advisory Board. All of the relevant financial relationships listed for this individual have been mitigated.

None of the planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.